Fundraising FoxLamina
Strasbourg, FR · 1 known investors
Find your way into Lamina
Sign up to see every warm intro you have to Lamina
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Lamina team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Lamina Therapeutics develops Lamina.One, a combined advanced therapy medicinal product for bone and cartilage regeneration that pairs a biodegradable polymeric membrane with hydroxyapatite and an autologous mesenchymal stem cell hydrogel to treat knee osteoarthritis and orthopaedic, maxillofacial, and periodontal conditions. A spin-off from INSERM and the University of Strasbourg's Regenerative Nanomedicine unit, it has EMA and ANSM authorization for a Phase I clinical trial in Strasbourg, France.
Founders & leadership
Investors · 1
NLClisted by NLCAmsterdam
How we know: NLC's portfolio page · Not right? Tell us
Frequently asked questions
- What does Lamina do?
- Lamina Therapeutics develops Lamina.One, a combined advanced therapy medicinal product for bone and cartilage regeneration that pairs a biodegradable polymeric membrane with hydroxyapatite and an autologous mesenchymal stem cell hydrogel to treat knee osteoarthritis and orthopaedic, maxillofacial, and periodontal conditions. A spin-off from INSERM and the University of Strasbourg's Regenerative Nanomedicine unit, it has EMA and ANSM authorization for a Phase I clinical trial in Strasbourg, France.
- Who founded Lamina?
- Lamina was founded by Nadia Benkirane-Jessel.
- Who are Lamina's investors?
- Lamina's investors include NLC.
- Where is Lamina headquartered?
- Lamina is headquartered in Strasbourg, FR.